Major depressive disorder. Major depressive disorder, single episode, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In group B, the anesthesia process is induced by intravenous injection of 0.5 mg / kg Ketamine with 0.5 mg / kg Propofol (Ketofol) and injection of 0.5 mg / kg Succ
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: All patients with major depressive disorder candidates for Electro Convulsive Therapy referred to Arak Amirkabir Hospital All patients candidates for Electro-Convulsive Therapy who have signed an informed consent form to enter the study Patients in the age range of 18 to 60 years Patients with a BMI in the range of 20 to 30 Patients with major depressive disorder who do not have another psychiatric illness at the same time
Exclusion criteria
Exclusion criteria: Pregnancy Breastfeeding sensitivity to Remifentanil or Thiopental or Propofol taking anticonvulsant drugs recent CVA or MI history history of underlying diseases of the heart, lungs, kidneys and liver
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean Arterial Pressure. Timepoint: Beginning and the end of recovery. Method of measurement: Monitor.;Pulse Rate. Timepoint: Beginning and the end of recovery. Method of measurement: Monitor.;Pulse oximetry (SpO2). Timepoint: Beginning and the end of recovery. Method of measurement: Monitor.;Satisfaction score. Timepoint: After recovery. Method of measurement: questionnaire.;Agitation Score. Timepoint: After recovery. Method of measurement: questionnaire.;Duration of seizures. Timepoint: beginning and the end of seizures. Method of measurement: Minutes with chronometer.;Duration of recovery. Timepoint: Beginning and the end of recovery. Method of measurement: Chronometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Alireza Kamali
Arak University of Medical Sciences
Outcome results
None listed